Pharmacodynamic and Pharmacokinetic Dose Ranging Study of Tiotropium Bromide Administered Via Inhalation Solution in Patients With Chronic Obstructive Pulmonary Disease (COPD)
Public ClinicalTrials.gov record NCT03118765. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Dose Ranging, Parallel Group, Active (Spiriva® Respimat®) And Placebo Controlled Study To Assess Relative Bioavailability, Pharmacodynamics And Safety Of Three Doses Of Tiotropium Bromide Inhalation Solution In Subjects With Mild To Moderate Chronic Obstructive Pulmonary Disease
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
Pharmacodynamic and Pharmacokinetic Dose Ranging Study of Tiotropium Bromide Administered Via Inhalation Solution in Patients With Chronic Obstructive Pulmonary Disease (COPD).
Study identification
- NCT ID
- NCT03118765
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 155 participants
Conditions and interventions
Interventions
- GSP304 (tiotropium bromide) Inhalation Solution Drug
- GSP304 Placebo Inhalation Solution Drug
- Spiriva® Respimat® inhalation spray Drug
Drug
Eligibility (public fields only)
- Age range
- 40 Years to 85 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Mar 24, 2017 (Actual)
- Primary completion
- Jul 31, 2017 (Actual)
- Completion
- Jul 31, 2017 (Actual)
- Last update posted
- Aug 1, 2019
2017
United States locations
- U.S. sites
- 25
- U.S. states
- 10
- U.S. cities
- 21
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Glenmark Investigational Site 23 | Andalusia | Alabama | 36420 | — |
| Glenmark Investigational Site 12 | Phoenix | Arizona | 85006 | — |
| Glenmark Investigational Site 14 | Tempe | Arizona | 85283 | — |
| Glenmark Investigational Site 17 | Fullerton | California | 92835 | — |
| Glenmark Investigational Site 19 | Edgewater | Florida | 32132 | — |
| Glenmark Investigational Site 24 | Miami | Florida | 33144 | — |
| Glenmark Investigational Site 16 | Miami | Florida | 33186 | — |
| Glenmark Investigational Site 10 | Miami Lakes | Florida | 33016 | — |
| Glenmark Investigational Site 6 | Orlando | Florida | 32825 | — |
| Glenmark Investigational Site 20 | Ormond Beach | Florida | 32124 | — |
| Glenmark Investigational Site 21 | Vero Beach | Florida | 32960 | — |
| Glenmark Investigational Site 13 | Winter Park | Florida | 32789 | — |
| Glenmark Investigational Site 18 | Las Vegas | Nevada | 89119 | — |
| Glenmark Investigational Site 9 | Charlotte | North Carolina | 28207 | — |
| Glenmark Investigational Site 5 | Columbus | Ohio | 43213 | — |
| Glenmark Investigational Site 22 | Columbus | Ohio | 43215 | — |
| Glenmark Investigational Site 8 | Dublin | Ohio | 43016 | — |
| Glenmark Investigational Site 11 | Medford | Oregon | 97504-9741 | — |
| Glenmark Investigational Site 3 | Easley | South Carolina | 29640 | — |
| Glenmark Investigational Site 2 | Greenville | South Carolina | 29615 | — |
| Glenmark Investigational Site 4 | Greenville | South Carolina | 29615 | — |
| Glenmark Investigational Site 1 | Rock Hill | South Carolina | 29732 | — |
| Glenmark Investigational Site 15 | Spartanburg | South Carolina | 29303 | — |
| Glenmark Investigational Site 7 | Spartanburg | South Carolina | 29303 | — |
| Glenmark Investigational Site 25 | Tomball | Texas | 77375 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03118765, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Aug 1, 2019 · Synced Oct 17, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT03118765 live on ClinicalTrials.gov.